181 related articles for article (PubMed ID: 27893714)
21. MiRNA203 suppresses the expression of protumorigenic STAT1 in glioblastoma to inhibit tumorigenesis.
Yang CH; Wang Y; Sims M; Cai C; He P; Yue J; Cheng J; Boop FA; Pfeffer SR; Pfeffer LM
Oncotarget; 2016 Dec; 7(51):84017-84029. PubMed ID: 27705947
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-217 functions as a prognosis predictor and inhibits colorectal cancer cell proliferation and invasion via an AEG-1 dependent mechanism.
Wang B; Shen ZL; Jiang KW; Zhao G; Wang CY; Yan YC; Yang Y; Zhang JZ; Shen C; Gao ZD; Ye YJ; Wang S
BMC Cancer; 2015 May; 15():437. PubMed ID: 26016795
[TBL] [Abstract][Full Text] [Related]
23. Ajuba Overexpression Promotes Breast Cancer Chemoresistance and Glucose Uptake through TAZ-GLUT3/Survivin Pathway.
Li X; Zhao G; Mi X; Xu T; Li X; Liu B
Biomed Res Int; 2022; 2022():3321409. PubMed ID: 35178446
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
[TBL] [Abstract][Full Text] [Related]
25. LDB1 overexpression is a negative prognostic factor in colorectal cancer.
García SA; Swiersy A; Radhakrishnan P; Branchi V; Kanth Nanduri L; Győrffy B; Betzler AM; Bork U; Kahlert C; Reißfelder C; Rahbari NN; Weitz J; Schölch S
Oncotarget; 2016 Dec; 7(51):84258-84270. PubMed ID: 27713177
[TBL] [Abstract][Full Text] [Related]
26. RNA interference against TRIM29 inhibits migration and invasion of colorectal cancer cells.
Xu W; Xu B; Yao Y; Yu X; Cao H; Zhang J; Liu J; Sheng H
Oncol Rep; 2016 Sep; 36(3):1411-8. PubMed ID: 27430345
[TBL] [Abstract][Full Text] [Related]
27. TACC3 promotes colorectal cancer tumourigenesis and correlates with poor prognosis.
Du Y; Liu L; Wang C; Kuang B; Yan S; Zhou A; Wen C; Chen J; Wu Y; Yang X; Feng G; Liu B; Iwamoto A; Zeng M; Wang J; Zhang X; Liu H
Oncotarget; 2016 Jul; 7(27):41885-41897. PubMed ID: 27248823
[TBL] [Abstract][Full Text] [Related]
28. STAT1 modification improves therapeutic effects of interferons on lung cancer cells.
Chen J; Zhao J; Chen L; Dong N; Ying Z; Cai Z; Ji D; Zhang Y; Dong L; Li Y; Jiang L; Holtzman MJ; Chen C
J Transl Med; 2015 Sep; 13():293. PubMed ID: 26351076
[TBL] [Abstract][Full Text] [Related]
29. The LIM protein Ajuba influences interleukin-1-induced NF-kappaB activation by affecting the assembly and activity of the protein kinase Czeta/p62/TRAF6 signaling complex.
Feng Y; Longmore GD
Mol Cell Biol; 2005 May; 25(10):4010-22. PubMed ID: 15870274
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of FOXK1 alone or in combination with apoptosis-inducing 5-FU inhibits cell growth in colorectal cancer.
Wu Y; Xie R; Liu X; Wang J; Peng Y; Tang W; Wu M; Zhang P; Ba Y; Zhao J; Li A; Nan Q; Chen Y; Liu S; Wang J
Oncol Rep; 2016 Oct; 36(4):2151-9. PubMed ID: 27571921
[TBL] [Abstract][Full Text] [Related]
31. Aspirin enhances IFN-α-induced growth inhibition and apoptosis of hepatocellular carcinoma via JAK1/STAT1 pathway.
Li T; Dong ZR; Guo ZY; Wang CH; Tang ZY; Qu SF; Chen ZT; Li XW; Zhi XT
Cancer Gene Ther; 2013 Jun; 20(6):366-74. PubMed ID: 23703473
[TBL] [Abstract][Full Text] [Related]
32. Thyrotropin modulates interferon-gamma-mediated intercellular adhesion molecule-1 gene expression by inhibiting Janus kinase-1 and signal transducer and activator of transcription-1 activation in thyroid cells.
Chung J; Park ES; Kim D; Suh JM; Chung HK; Kim J; Kim H; Park SJ; Kwon OY; Ro HK; Shong M
Endocrinology; 2000 Jun; 141(6):2090-7. PubMed ID: 10830295
[TBL] [Abstract][Full Text] [Related]
33. Identification of genes with universally upregulated or downregulated expressions in colorectal cancer.
Song K; Su W; Liu Y; Zhang J; Liang Q; Li N; Guan Q; He J; Bai X; Zhao W; Guo Z
J Gastroenterol Hepatol; 2019 May; 34(5):880-889. PubMed ID: 30395690
[TBL] [Abstract][Full Text] [Related]
34. Exenatide blocks JAK1-STAT1 in pancreatic beta cells.
Couto FM; Minn AH; Pise-Masison CA; Radonovich M; Brady JN; Hanson M; Fernandez LA; Wang P; Kendziorski C; Shalev A
Metabolism; 2007 Jul; 56(7):915-8. PubMed ID: 17570252
[TBL] [Abstract][Full Text] [Related]
35. Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development.
Piao MY; Cao HL; He NN; Xu MQ; Dong WX; Wang WQ; Wang BM; Zhou B
Scand J Gastroenterol; 2016; 51(5):572-82. PubMed ID: 26691157
[TBL] [Abstract][Full Text] [Related]
36. Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway.
Ren D; Lin B; Zhang X; Peng Y; Ye Z; Ma Y; Liang Y; Cao L; Li X; Li R; Sun L; Liu Q; Wu J; Zhou K; Zeng J
Oncotarget; 2017 Jul; 8(30):49807-49823. PubMed ID: 28591704
[TBL] [Abstract][Full Text] [Related]
37. siRNA-mediated knockdown of JUB expression suppresses the proliferation of glioblastoma cells.
Ouyang H; Guo Z; Cheng Z; Guo Y
Cancer Biomark; 2015; 15(4):477-84. PubMed ID: 26406867
[TBL] [Abstract][Full Text] [Related]
38. Epigallocatechin-3-gallate sensitizes IFN-γ-stimulated CD4+ T cells to apoptosis via alternative activation of STAT1.
Wu X; Shao F; Yang Y; Gu L; Zheng W; Wu X; Gu Y; Shu Y; Sun Y; Xu Q
Int Immunopharmacol; 2014 Dec; 23(2):434-41. PubMed ID: 25261409
[TBL] [Abstract][Full Text] [Related]
39. Smad1 promotes colorectal cancer cell migration through Ajuba transactivation.
Yang D; Hou T; Li L; Chu Y; Zhou F; Xu Y; Hou X; Song H; Zhu K; Hou Z; Peng H; Jia H
Oncotarget; 2017 Dec; 8(66):110415-110425. PubMed ID: 29299158
[TBL] [Abstract][Full Text] [Related]
40. miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1.
Liu Y; Liu R; Yang F; Cheng R; Chen X; Cui S; Gu Y; Sun W; You C; Liu Z; Sun F; Wang Y; Fu Z; Ye C; Zhang C; Li J; Chen X
Mol Cancer; 2017 Mar; 16(1):53. PubMed ID: 28257633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
